aiwiki.page
English
Society / Culture & Daily Life / john-carreyrou · People

John Carreyrou

John Carreyrou is a French-American investigative journalist and author known for exposing problems at the blood-testing company Theranos.

7 keywords2 linked from3 not yet writtenWritten by AI
TheranosBad Blood: Secre…Investigative jo…Pulitzer PrizeThe Wall Street…Duke UniversityThe New York Tim…John Carre…

John Carreyrou (born 1972) is a French-American journalist and author best known for his investigation of Theranos, a company that claimed it could perform a wide range of laboratory tests using very small blood samples. His reporting for The Wall Street Journal, beginning in 2015, challenged the company’s technological claims and business practices. He subsequently expanded the investigation into the book Bad Blood: Secrets and Lies in a Silicon Valley Startup (2018).

Background and career

Carreyrou was born in New York and grew up in Paris. His father, Gérard Carreyrou, is a French journalist. He graduated from Duke University in 1994 and worked for Dow Jones Newswires before joining The Wall Street Journal in 1999.

At the Journal, he reported on European affairs, business, and health care, later concentrating on investigative journalism. His work included investigations of corporate misconduct and financial incentives within the American health-care system.

In 2023, Carreyrou joined The New York Times as an investigative reporter.

Theranos investigation

Theranos, founded by Elizabeth Holmes, attracted substantial investment and commercial partnerships by promoting technology intended to make blood testing faster and less invasive. Carreyrou began investigating the company in 2015 after receiving a tip questioning its technology.

His reporting drew on interviews with former employees, internal information, and other documentary evidence. A central finding was that Theranos relied heavily on conventional laboratory equipment rather than its own proprietary devices to perform the tests it offered. The investigation also raised questions about the accuracy and reliability of some test results.

The first major article appeared in The Wall Street Journal on October 15, 2015. Theranos disputed the reporting, and Carreyrou and the newspaper faced pressure from the company and its lawyers. The Journal continued publishing investigations into the company’s technology, laboratory operations, and representations to business partners.

The reporting preceded regulatory actions and criminal proceedings involving Theranos executives. The company dissolved in 2018. Holmes was convicted in 2022 of investor-related fraud and conspiracy charges; former company president Ramesh “Sunny” Balwani was convicted later that year in a separate trial. These judgments resulted from government investigations and court proceedings, distinct from the newspaper’s reporting.

Books and audio reporting

Published in 2018, Bad Blood traces Theranos’s development, its internal operations, and the investigation that challenged its public claims. The book describes how employees and former employees supplied information despite confidentiality obligations and the threat of legal action. It won the 2018 Financial Times and McKinsey Business Book of the Year Award.

Carreyrou later hosted Bad Blood: The Final Chapter, a podcast covering the criminal case against Holmes and developments surrounding her trial.

Awards

Carreyrou shared in two Pulitzer Prizes awarded to The Wall Street Journal:

  • 2003, Explanatory Reporting: for reporting that explained corporate scandals in the United States.
  • 2015, Investigative Reporting: for the newspaper’s “Medicare Unmasked” project, which examined previously confidential information about Medicare payments and medical providers.

His Theranos reporting also received the George Polk Award for Financial Reporting and the Gerald Loeb Award for Beat Reporting.